Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?

Core Insights - The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a passively managed ETF launched on November 1, 2006, providing broad exposure to the Healthcare - Broad segment of the equity market [1] - The Healthcare - Broad sector is ranked 8th among the 16 Zacks sectors, placing it in the top 50% [2] Fund Overview - Sponsored by Invesco, RSPH has over $717.51 million in assets, making it one of the larger ETFs in the Healthcare - Broad segment [3] - The ETF aims to match the performance of the S&P 500 Equal Weight Health Care Index, which equally weights stocks in the healthcare sector of the S&P 500 Index [3] Cost Structure - RSPH has an annual operating expense ratio of 0.40%, positioning it as one of the cheaper options in the ETF space [4] - The ETF has a 12-month trailing dividend yield of 0.76% [4] Sector Exposure and Holdings - The ETF is fully allocated to the Healthcare sector, with approximately 100% of its portfolio dedicated to this area [5] - Moderna Inc (MRNA) constitutes about 1.82% of total assets, with the top 10 holdings accounting for approximately 17.56% of total assets under management [6] Performance Metrics - As of July 24, 2025, RSPH has gained about 0.04% year-to-date but is down approximately -4.35% over the past year [7] - The ETF has traded between $26.81 and $32.53 in the last 52 weeks, with a beta of 0.83 and a standard deviation of 15.65% over the trailing three-year period [7] Alternatives - RSPH carries a Zacks ETF Rank of 3 (Hold), indicating it is a viable option for investors seeking exposure to the Health Care ETFs market [8] - Other alternatives include the Vanguard Health Care ETF (VHT) and the Health Care Select Sector SPDR ETF (XLV), with VHT having $15.51 billion in assets and XLV having $33.63 billion [9]